Pituitary hemorrhage : classification and related factors.
OBJECTIVE
Clinical features of pituitary hemorrhage vary from asymptomatic to catastrophic. The purpose of this study was to evaluate the factors related to severity of hemorrhage of pituitary adenoma.


METHODS
Pituitary hemorrhage was noted in 32 of 88 patients who underwent operations between January 2000 and December 2007. Clinical status was classified into group I (no hemorrhage symptoms), II (mild to moderate symptoms without neurological deficit), and III (with neurological deficit), and was compared to radiological, pathological, and operative findings. All patients were operated by transsphenoidal approach, and hemorrhage-related symptoms were relieved.


RESULTS
Groups I, II, and III comprised 15, 10 and 7 patients, respectively. In group I, hemorrhage volume was under 1 mL in 11 (73.3%), but, it was above 1 mL in 7 (70%) of group II and in all cases of group III. Hemorrhage stage based on MRI findings was chronic or subacute in 11 (73.3%) of group I, acute in 6 (60%) of group II, and acute or hyperacute in 6 (85.7%) of group III. Pathological examination revealed chronic-stage hematomas in 5 (50%) group II patients. Functioning adenomas were found in 5 (33.3%) group I patients but none in group II or III patients. Silent adenomas were found in 4 (26.7%), 8 (80%), and 3 (42.9%) in groups I, II, and III, respectively.


CONCLUSIONS
Clinical features of pituitary hemorrhage may differ with the radiological and immunohistopathlogical findings. Persistent symptoms are related to the chronic stage of hematoma requiring surgery for symptom relief. Neurological deficits are caused by large amount of acute hemorrhage requiring emergency operation. Silent adenoma is related to the severity of pituitary hemorrhage.
Kim
Dae-Jin
DJ
Brain Tumor Institute, College of Medicine, Dong-A University, Busan, Korea.
Song
Young-Jin
YJ
Kim
Su-Jin
SJ
Park
Mi-Kyoung
MK
Choi
Sun-Seob
SS
Kim
Ki-Uk
KU
Surg Neurol. 1982 Sep;18(3):181-9
7179072
J Neurosurg. 1991 Dec;75(6):902-5
1941118
Neurosurgery. 1984 Mar;14(3):363-73
6369168
Clin Endocrinol (Oxf). 2003 Jan;58(1):59-64
12519413
J Neurosurg. 2008 May;108(5):909-15
18447705
Eur Radiol. 1998;8(6):971-6
9683703
Clin Endocrinol (Oxf). 1999 Aug;51(2):181-8
10468988
Neurosurg Focus. 2004 Apr 15;16(4):E6
15191335
J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):542-5
11561045
J Intensive Care Med. 2008 Mar-Apr;23(2):75-90
18372348
Neurosurgery. 1990 Jun;26(6):980-6
2362675
Acta Neurochir (Wien). 2005 Dec;147(12):1249-56; discussion 1256-7
16133770
J Comput Assist Tomogr. 1990 Jan-Feb;14(1):40-4
2298995
Neurosurgery. 1993 Oct;33(4):602-8; discussion 608-9
8232799
J Clin Endocrinol Metab. 1981 Jan;52(1):95-7
6256408
Pituitary. 2004;7(3):157-163
16010459
J Clin Endocrinol Metab. 1995 Jul;80(7):2190-7
7608278
J Neurosurg. 1983 Mar;58(3):315-20
6827315
Neurosurgery. 1990 Aug;27(2):214-8; discussion 218-9
2385339
J Neurosurg. 1981 Aug;55(2):187-93
7252541
Radiographics. 2006 Jan-Feb;26(1):93-113
16418246
J Neurosurg. 1972 Sep;37(3):280-8
5069376
Neurosurgery. 2005;56(1):65-72; discussion 72-3
15617587